Search Results - "Coleman, C.Norman"

Analysis of prostate and seminal vesicle motion: implications for treatment planning by Beard, C J, Kijewski, P, Bussière, M, Gelman, R, Gladstone, D, Shaffer, K, Plunkett, M, Castello, P, Coleman, C N

“…To quantify prostate and seminal vesicle positional changes (target motion) between treatment planning and delivery, and to identify the factors contributing…”
Get more information

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment by Trotti, Andy, Colevas, A.Dimitrios, Setser, Ann, Rusch, Valerie, Jaques, David, Budach, Volker, Langer, Corey, Murphy, Barbara, Cumberlin, Richard, Coleman, C.Norman, Rubin, Philip

“…Multiple systems have been developed for grading the adverse effects (AEs) of cancer treatment. The National Cancer Institute Common Toxicity Criteria (CTC)…”
Get full text

Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial by Riese, N E, Buswell, L, Noll, L, Pajak, T F, Stetz, J, Lee, D J, Coleman, C N

“…To prospectively evaluate the pharmacokinetic monitoring and drug dose adjustment of Etanidazole (Eta) in patients treated on the RTOG randomized trial for…”
Get more information

MRI-guided HDR prostate brachytherapy in standard 1.5T scanner by Ménard, Cynthia, Susil, Robert C, Choyke, Peter, Gustafson, Gary S, Kammerer, William, Ning, Holly, Miller, Robert W, Ullman, Karen L, Sears Crouse, Nancy, Smith, Sharon, Lessard, Etienne, Pouliot, Jean, Wright, Victor, McVeigh, Elliot, Coleman, C Norman, Camphausen, Kevin

“…Magnetic resonance imaging (MRI) provides superior visualization of the prostate and surrounding anatomy, making it the modality of choice for imaging the…”
Get more information

Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03 by Coleman, C N, Wasserman, T H, Urtasun, R C, Halsey, J, Noll, L, Hancock, S, Phillips, T L

“…In a Phase I trial SR 2508 was administered by rapid intravenous infusion to 102 patients receiving radiation therapy. The dose-limiting toxicity was…”
Get more information

Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma by Chang, E L, Loeffler, J S, Riese, N E, Wen, P Y, Alexander, 3rd, E, Black, P M, Coleman, C N

“…To report the survival results from a previous Phase I study of etanidazole (ETA) and radiotherapy in patients with glioblastoma multiforme (GBM n = 50) or…”
Get more information

Urologic oncology: extraordinary opportunities for discovery by Coleman, C.Norman

Get full text

Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development by Yoo, Stephen S, Jorgensen, Timothy J, Kennedy, Ann R, Boice, Jr, John D, Shapiro, Alla, Hu, Tom C-C, Moyer, Brian R, Grace, Marcy B, Kelloff, Gary J, Fenech, Michael, Prasanna, Pataje G S, Coleman, C Norman

“…The United States radiation medical countermeasures (MCM) programme for radiological and nuclear incidents has been focusing on developing mitigators for the…”
Get more information

Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer by D'Amico, A V, Cormack, R, Tempany, C M, Kumar, S, Topulos, G, Kooy, H M, Coleman, C N

“…This study was performed to establish the dose-localization capability and acute toxicity of a real-time intraoperative magnetic resonance (MR) image-guided…”
Get more information

International Conference on Translational Research ICTR 2003 Conference Summary: marshalling resources in a complex time by Coleman, C Norman

“…The knowledge, tools, and environment for the practice of radiation oncology are changing rapidly. The National Cancer Institute has articulated the need for a…”
Get more information

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma by Marcus, Karen J, Dutton, Sharon C, Barnes, Patrick, Coleman, C Norman, Pomeroy, Scott L, Goumnerova, Liliana, Billett, Amy L, Kieran, Mark, Tarbell, Nancy J

“…To determine the toxicity and maximum tolerated dose of etanidazole administered concurrently with hyperfractionated radiation therapy (HRT) for children with…”
Get more information

Second Malignancies After Treatment for Laparotomy Staged IA-IIIB Hodgkin's Disease: Long-Term Analysis of Risk Factors and Outcome by Mauch, Peter M., Kalish, Leslie A., Marcus, Karen C., Coleman, C.Norman, Shulman, Lawrence N., Krill, Elisa, Come, Steven, Silver, Barbara, Canellos, George P., Tarbell, Nancy J.

“…The survival of patients with Hodgkin's disease has dramatically improved over the past 30 years because of advances in treatment. However, concern for the…”
Get full text

New directions in brachytherapy by Cumberlin, Richard L, Coleman, C Norman

Get more information

Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated by Camphausen, Kevin, Ménard, Cynthia, Sproull, Mary, Goley, Elizabeth, Basu, Samar, Coleman, C Norman

“…Previous studies have demonstrated that urinary 8-iso-prostaglandin F (PGF)2alpha serves as a powerful biomarker of lipid peroxidation in diseases in which…”
Get more information

Young Investigators Workshop--Radiation Research Program, Radiation Oncology Sciences Program, National Cancer Institute, NIH, August 1-2 2000 by Coleman, C N

Get more information

International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR)--conference summary by Coleman, C N

Get more information

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results by Ménard, Cynthia, Camphausen, Kevin, Muanza, Thierry, Sears-Crouse, Nancy, Smith, Sharon, Ben-Josef, Edgar, Coleman, C.Norman

“…Tolerance of the normal rectal mucosa to radiation injury limits the dose that can be safely delivered to the prostate gland with definitive external beam…”
Get full text

Evaluation of copper chelation agents as anti-angiogenic therapy by Camphausen, Kevin, Sproull, Mary, Tantama, Steve, Sankineni, Sandeep, Scott, Tamalee, Ménard, Cynthia, Coleman, C.Norman, Brechbiel, Martin W

“…The design, synthesis and evaluation of N,N′ ,N′′-tris(2-pyridylmethyl)- cis,cis-1,3,5,-triaminocyclohexane (tachpyr, 1) derivatives as novel anti-angiogenic…”
Get full text

Translational research in radiation oncology by Coleman, C N, Cumberlin, R L

Get more information

We're from the government and we're here to help you by Coleman, C N, Cumberlin, R

Get more information